MedTrace Logo

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

NCT06892938 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 232

Last updated 2025-03-27

No results posted yet for this study

Summary

Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.

Conditions

  • Atrial Fibrillation (AF)
  • Arrhythmias Cardiac
  • Tachycardia
  • Palpitations
  • Bradycardia

Interventions

DIAGNOSTIC_TEST

Atrial Fibrillation Identification

Identification of atrial fibrillation by device.

Sponsors & Collaborators

  • Everbeat

    lead INDUSTRY

Principal Investigators

  • Kenneth Civello, MD · Our Lady of Lake Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-17
Primary Completion
2025-03-12
Completion
2025-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06892938 on ClinicalTrials.gov